Trial intelligence / Profile preview

Autologous MSCs vs TVT for Female Stress Urinary Incontinence

NCT02334878Phase 3Completed

Sponsor
Ain Shams University Maternity Hospital
Start
Oct 2015
Primary completion
Oct 2016
Modality
Stem Cell Therapies
Countries
1
01

Overview

A Phase 3 trial of autologous bone marrow derived mesenchymal stromal cells in stress urinary incontinence (SUI), sponsored by Ain Shams University Maternity Hospital. Started Oct 2015; status: completed.

02

Drugs

autologous bone marrow derived mesenchymal stromal cells
03

Conditions

stress urinary incontinence (SUI)

Beyond the preview

Go deeper on NCT02334878.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02334878.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call